VRDN (STOCKS)
Viridian Therapeutics, Inc. Common Stock
$16.400000
+0.050000 (+0.31%)
Prev close: $16.350000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Stephen Frank Mahoney
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,799.98M
- Employees
- 143
- P/E (TTM)
- -4.33
- P/B (TTM)
- 3.32
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
13
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.90 | $-1.12 | +0.2162 | +19.37% |
|
Dec 2025 (Q4)
|
$-1.08 | $-1.09 | +0.0105 | +0.96% |
|
Sep 2025 (Q3)
|
$-0.34 | $-1.10 | +0.7644 | +69.21% |
|
Jun 2025 (Q2)
|
$-1.00 | $-1.03 | +0.0296 | +2.87% |
Financial Statements
| Revenues | $70.92M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $456.62M |
| Nonoperating Income/Loss | $25.11M |
| Operating Expenses | $456.62M |
| Selling, General, and Administrative Expenses | $116.89M |
| Other Operating Expenses | $339.73M |
| Operating Income/Loss | -$385.70M |
| Income/Loss From Continuing Operations After Tax | -$360.59M |
| Income/Loss From Continuing Operations Before Tax | -$29.89M |
| Net Income/Loss | -$360.59M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$360.59M |
| Net Income/Loss Available To Common Stockholders, Basic | -$360.59M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Assets | $789.02M |
| Current Assets | $784.74M |
| Cash | $762.20M |
| Other Current Assets | $22.54M |
| Noncurrent Assets | $4.27M |
| Fixed Assets | $1.13M |
| Other Non-current Assets | $3.14M |
| Liabilities | $153.01M |
| Current Liabilities | $51.81M |
| Accounts Payable | $13.31M |
| Wages | $8.36M |
| Other Current Liabilities | $30.13M |
| Noncurrent Liabilities | $101.20M |
| Equity | $636.01M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $636.01M |
| Liabilities And Equity | $789.02M |
| Net Cash Flow From Operating Activities | -$303.39M |
| Net Cash Flow From Operating Activities, Continuing | -$303.39M |
| Net Cash Flow From Investing Activities | -$60.36M |
| Net Cash Flow From Investing Activities, Continuing | -$60.36M |
| Net Cash Flow From Financing Activities | $423.89M |
| Net Cash Flow From Financing Activities, Continuing | $423.89M |
| Net Cash Flow | $60.13M |
| Net Cash Flow, Continuing | $60.13M |
| Comprehensive Income/Loss | -$361.22M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$361.39M |
| Other Comprehensive Income/Loss | -$260.48M |
| Other Comprehensive Income/Loss Attributable To Parent | -$803.00K |